Chronic Hepatitis Therapeutics Market Is Estimated to Grow at CAGR of 12%, 2022-2030 | Latest Industry Coverage By Growth Plus Reports

Growth Plus Reports
·5 min read
Growth Plus Reports
Growth Plus Reports

Pune, Nov. 28, 2022 (GLOBE NEWSWIRE) -- According to a new market research report titled, “Chronic Hepatitis Therapeutics Market by Drug Class (Interferons Alphas, NS5A Inhibitors Nucleoside/Nucleotide Analogues, Thrombopoiesis Stimulating Agents, and Others), by Distribution Channel (Hospital, Retail and Online Pharmacies) – Global Outlook & Forecast 2022-2030" published by Growth Plus Reports, the Chronic Hepatitis Therapeutics Market is expected to grow at a CAGR of 12% from 2021 to reach US$ 31.16 billion by 2030.

Download Sample PDF Brochure of Chronic Hepatitis Therapeutics Market:

https://growthplusreports.com/inquiry/request-sample/chronic-hepatitis-therapeutics-market/7985

Market Drivers

About 2300 compounds are being studied for the therapy of hepatitis C infection, and about 300 are in phase 4 research. The development of drugs to cure hepatitis C is being undertaken by numerous businesses. As a result, new products would be created, ultimately driving the market. Additionally, the development of novel hepatitis drugs for the treatment of various types of hepatitis as well as expanding research and development work, clinical trials of hepatitis drugs. Significant market growth is encouraged by expanding research collaboration for the development of powerful medications in the pipeline. Additionally, alliances and joint initiatives within significant organisations are raising ongoing knowledge of hepatitis therapeutics treatment, and the promotion of affordable hepatitis therapeutics is a unique factor that fosters market growth.

Excerpts from ‘By Drug Class Segmentation’

Based on drug class, global chronic hepatitis therapeutics market has been segmented into

  • Interferons Alphas

  • Ns5a Inhibitors

  • Nucleoside/Nucleotide Analogues

  • Thrombopoiesis Stimulating Agents

  • Others

The interferons alphas dominated the segment during forecast period and NS5a inhibitors is the fastest growing segment. For hepatitis C, direct-acting antivirals (DAAs) are the most often used medication. Typically, they are taken as pills. In up to 90 to 97 percent of instances, these drugs can successfully treat hepatitis C. Trusted Source They function by assisting in preventing the hepatitis C virus's growth. There are three kinds of DAAs including NS3/4 protease inhibitors, NS5A inhibitors and NS5B polymerase inhibitors. Furthermore, PEG-IFN and ribavirin combination therapy is currently the gold standard of care.  For genotypes 1 or 4 and genotypes 2 or 3, NICE has recommended a single course of treatment lasting 48 weeks and 24 weeks, respectively, with SVR (cure) rates of roughly 45% and 80%. Although combination antiviral therapy is pricey, it is cost-effective for treating HCV infection at all stages, including moderate fibrosis.

Excerpts from ‘By Region Segmentation’

Based on region, the chronic hepatitis therapeutics market is segmented into

  • North America

  • Europe

  • Asia Pacific

  • Rest Of The World

Due to the growing number of hepatitis C patients and the presence of major companies like Vertex Pharmaceuticals Incorporated, AbbVie Inc., Bristol-Myers Squibb Company, Abbott, Beckman Coulter, Inc., Hologic, Inc., and Bio-Rad Laboratories, Inc. in the region, the North America are anticipated to dominate the chronic hepatitis therapeutics market. The Centers for Disease Control and Prevention recently released a report estimating that 2.4 million people in the US are affected by hepatitis C. Additionally, Asia-Pacific is expected to be the fastest-growing regional market because of the enormous patient population suffering from hepatitis C and the growing number of government and private institute endeavours to create awareness about hepatitis C.

Excerpts from ‘Competitive Landscape’

Some of the prominent market players in the global chronic hepatitis therapeutics market include

  • Genentech, Inc.

  • Bluejay Therapeutics Inc.

  • Gsk Plc.

  • Gilead Sciences, Inc.

  • Novartis Pharmaceuticals Corporation

  • Bristol-Myers Squibb Company

  • Lupin

  • Sun Pharmaceutical Industries Ltd.

  • Natco Pharma Limited

  • Teva Pharmaceutical Industries Ltd.

  • F. Hoffmann-La Roche Ltd.

  • Abbvie Inc.

Furthermore, the market for hepatitis medications is experiencing a substantial trend of new product introductions. To increase their market share, the major players in the hepatitis medicine industry are concentrating on introducing innovative products for hepatitis treatments. However, due to high incidence rates and a rise in the import of generic medications to treat various hepatitis illnesses, MEA and Latin America are predicted to experience significant growth. Due to the outstanding results of HCV treatments, the patient population in the United States and other industrialised nations is declining. To address the enormous unmet need for better treatment, several manufacturers are expanding their operations in the MEA and Latin America regions.

Inquire Before Buying This Research Report:

https://growthplusreports.com/inquiry/before-buying/chronic-hepatitis-therapeutics-market/7985

Table of Content

  1. INTRODUCTION

    1. Market Ecosystem

    2. Timeline Under Consideration

      1. Historical Years - 2020

      2. Base Years - 2021

      3. Forecasted Years – 2022 to 2030

    3. Currency Used in the Report

  2. RESEARCH METHODOLOGY 

    1. Research Approach

    2. Data Collection Methodology

    3. Data Sources

      1. Secondary Sources

      2. Primary Sources

    4. Market Estimation Approach

      1. Bottom Up

      2. Top Down

    5. Market Forecasting Model

    6. Limitations and Assumptions       

  3. PREMIUM INSIGHTS

    1. Current Market Trend (COVID-19 Perspective)

    2. Key Players & Competitive Positioning (2021)

  4. MARKET DYNAMICS

    1. Drivers

    2. Restraints/Challenges

    3. Opportunities

  5. GLOBAL CHRONIC HEPATITIS THERAPEUTICS MARKET - ANALYSIS & FORECAST, BY DRUG CLASS

    1. Interferons Alphas

    2. NS5A Inhibitors

    3. Nucleoside/Nucleotide Analogues

    4. Thrombopoiesis Stimulating Agents

    5. Others

  6. GLOBAL CHRONIC HEPATITIS THERAPEUTICS MARKET - ANALYSIS & FORECAST, BY DISTRIBUTION CHANNEL

    1. Hospitals Pharmacies

    2. Retail Pharmacies

    3. Online Pharmacies

TOC Continue…

Scope of the Report:

Report Attribute

Details

Market size value in 2021

US$ 11.2 billion

Revenue forecast in 2030

US$ 31.16 billion

Growth Rate

CAGR of 12% from 2022 to 2030

Base year for estimation

2021

Forecast period

2022-2030

Segments covered

by drug class, distribution channel, and region.

Regional scope

North America, Europe, Asia Pacific, and the Rest of the World (ROW)

VALUE PROPOSITIONS RELATED TO THE REPORT:

  • Powered with Complimentary Analyst Hours and Expert Interviews with Each Report

  • Comprehensive quantitative and qualitative insights at segment and sub-segment level

  • Covid 19 impact trends and perspective

  • Granular insights at global/regional/country level

  • Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment

  • Blanket coverage on competitive landscape

  • Winning imperatives

  • Exhaustive coverage on 'Strategic Developments' registered by leading players of the market

CUSTOMIZATION OPTIONS:

  • Distributor Landscape Assessment

  • Pipeline Assessment

  • Pricing Intelligence

  • Customer Base Assessment

  • Investment & Initiatives Analysis

  • 'Business Profile' of Key Players

Quickly Purchase Premium Copy of Chronic Hepatitis Therapeutics Market Report:

https://growthplusreports.com/checkout?_token=ip9dVuzm3yr34ZcYDDFemRrWSR6EvT0rjFr0gad6&report_id=7985&license=Single

About Us        

Growth Plus Reports is part of GRG Health, a global healthcare knowledge service company. We are proud members of EPhMRA (European Pharmaceutical Marketing Research Association).

Growth Plus portfolio of services draws on our core capabilities of secondary & primary research, market modelling & forecasting, benchmarking, analysis, and strategy formulation to help clients create scalable, ground-breaking solutions that prepare them for future growth and success.

We were awarded by the prestigious CEO Magazine as "Most Innovative Healthcare Market Research Company in 2020.

CONTACT: Manan Sethi Director, Market Insights Email: enquire@growthplusreports.com Phone no: +91 96545 76783 Web: https://growthplusreports.com/


Latest Stories

  • Residence program for construction workers doubled in capacity, will now accommodate 1000 immigrants

    The Government of Canada has announced that it is doubling the scope of a residence pilot program for out-of-status workers, which will now facilitate 1000 instead of 500 construction workers in the Greater Toronto Area (GTA). The pilot program was launched by the Immigration, Refugees and Citizenship Canada (IRCC) in partnership with the Canadian Labour Congress (CLC). The program, launched in 2019, is aimed at helping Canadian employers address critical labor shortages, the government says. Th

  • First Scouting Report: Can Kentucky avoid a ‘trap game’ at Mississippi?

    An early look ahead to the meeting between John Calipari’s Wildcats and Kermit Davis Jr.’s Rebels.

  • Two Burlington residents charged with drug trafficking

    The Halton Regional Police Service has charged two Burlington residents with offenses related to drug trafficking after concluding a two-month long investigation in Burlington. On January 18, 2023, investigators arrested the suspect at Pearson Airport after he arrived from abroad. A woman associated with the suspect was also arrested as she was in possession of the suspect vehicle at the time. A Criminal Code search warrant was executed at a residence on Plains Road in Burlington. As a result of

  • Memphis police disband unit that fatally beat Tyre Nichols

    MEMPHIS, Tenn. (AP) — The Memphis police chief disbanded the city's so-called Scorpion unit on Saturday, citing a “cloud of dishonor” from newly released video that showed some of its officers beating Tyre Nichols to death after stopping the Black motorist. Police Director Cerelyn “CJ” Davis acted a day after the harrowing video emerged, saying she listened to Nichols' relatives, community leaders and uninvolved officers in making the decision. Her announcement came as the nation and the city st

  • Couture leads Sharks past Penguins 6-4 to end four-game skid

    Logan Couture had two goals and three assists as the San Jose Sharks beat the Pittsburgh Penguins 6-4 on Saturday night to snap a four-game skid. Alexander Barabanov had a goal and two assists, Erik Karlsson added a goal and an assist, and Michael Eyssimont and Noah Gregor also scored for the Sharks, who are 4-5-4 in their last 13 games.

  • Wisconsin Herd vs. Greensboro Swarm - Game Highlights

    Watch the Game Highlights from Wisconsin Herd vs. Greensboro Swarm, 01/28/2023

  • Stockton Kings vs. Memphis Hustle - Game Highlights

    Watch the Game Highlights from Stockton Kings vs. Memphis Hustle, 01/28/2023

  • ‘An inclusive vision for Sacramento’: Mayor Steinberg begins new town hall series

    Saturday morning Sacramento Mayor Derrell Steinberg stood before a crowd gathered inside the cafeteria at West Campus High School. Announcing loudly into a microphone toward the crowd of his constituents “my goal as your mayor has always been to grow the economy but to grow it in an inclusive way,” said Mayor Steinberg. This speech and the following discussion marked the start of a new series of town halls planned for neighborhoods across Sacramento, to be scheduled every few weeks through the entire year.

  • We’ve Done Lots for Ukraine, but Winning Will Take Much More

    Mustafa Ciftci/Anadolu Agency via Getty ImagesWhile the Western commitment to send tanks to Ukraine was a welcome breakthrough, it should not be seen as a panacea. At this crucial juncture in the war between Russia and Ukraine, the outcome of the conflict is far from clear and it will take at least two major shifts in U.S. and NATO policies to capitalize on the successes achieved by Kyiv during the past year.The first change required is to recognize that it is time to move toward an even more ag

  • Rangers inexplicably ditch promoted Pride Night warmup jerseys

    The New York Rangers are drawing criticism for reneging on plans to wear Pride-themed warmup jerseys before their game against the Vegas Golden Knights on Friday.

  • NSW Coalition pledges feasibility study for specialist domestic violence courts

    Labor opposition says move a decade overdue, with similar courts already operating in Queensland and overseas

  • Florida Panthers rally for wild overtime win over Boston Bruins ahead of All-Star break

    ‘There’s no quit in that group,’ Panthers coach Paul Maurice said.

  • Medici Jewelry by Prince Lorenzo de' Medici Unveiled at the HRD Spring 2023 International Jewelry Design Awards

    New York, New York--(Newsfile Corp. - January 28, 2023) - On 22 January 2023, the 18th HRD International Jewelry Design Awards was held in Italy, the world capital of fashion and art. MEDICI Jewelry's Prince Lorenzo de' Medici, head of the Medici family, was invited to host the awards ceremony.Prince Lorenzo de' MediciTo view an enhanced version of this graphic, please visit:https://images.newsfilecorp.com/files/8722/152845_bcf40faef4721aec_001full.jpgMEDICI Jewelry also unveiled the design for

  • Giroux helps Senators scorch Canadiens 5-0

    OTTAWA — Claude Giroux scored twice and added an assist as the Ottawa Senators beat the Montreal Canadiens 5-0 Saturday night. With the win the Senators (23-23-3) are riding a three-game winning streak. Ottawa was coming off a 6-2 win over Toronto on Friday night. The Senators are now 6-2-0 in their last eight at home and are a perfect 24-for-24 on the penalty kill through that span. Alex DeBrincat, Mathieu Joseph and Derick Brassard also scored for Ottawa, while Anton Forsberg was solid making

  • Leonard scores 32, Clippers beat Hawks for 5th straight win

    ATLANTA (AP) — Kawhi Leonard scored 32 points, including a season-high five 3-pointers, Paul George added 23 points and the Los Angeles Clippers won their fifth straight game, a 120-113 victory over the Atlanta Hawks on Saturday night. Trae Young had 12 of his 31 points in the fourth quarter for the Hawks, who whittled a 14-point deficit down to four on De’Andre Hunter’s left corner 3 with 2:09 remaining. But they couldn’t get any closer after George buried a baseline jumper and Nicolas Batum hi

  • Near-perfect night from Degenhart propels Boise State past Colorado State

    Tyson Degenhart was nearly perfect from the field, making 10-of-11 shot attempts.

  • Leading Australian Olympic official Phil Coles dies aged 91

    SYDNEY (AP) — Phil Coles, who played key roles in getting an Australian team to the 1980 Moscow Olympics despite a U.S.-led boycott and later helped secure the 2000 Games for Sydney, has died, the Australian Olympic Committee said Sunday. He was 91. The AOC said Coles died Saturday, but didn't say where, although his hometown was Sydney. Coles was one of 24 International Olympic Committee members implicated in the bidding bribery scandal for the 2002 Salt Lake City Winter Olympics. He was offici

  • 1 dead, 4 injured in Baltimore shooting, crash: Police

    One person was killed and four others were injured following a shooting Saturday in Baltimore after a passenger was shot and crashed their car, police said. The police arrived at the scene to find two adult males, an adult female, and a 2-year-old boy, all of whom were suffering from apparent gun shot wounds. Medics transported the victims to area hospitals, where one of the adult male victims was pronounced dead.

  • Knierim, Frazier capture pairs gold at US skating nationals

    A long time coming getting back to the top of the podium, Alexa Knierim and Brandon Frazier captured another national pairs gold at the U.S. Figure Skating Championships on Saturday night with a spectacular free skate that scored them an overall season-best 227.97. The reigning world champions were forced to withdraw the night before last year's nationals when Frazier contracted COVID-19, denying them a chance to defend their 2021 title from their first season together. Skating second-to-last and ahead of eventual silver medalists Emily Chan and Spencer Howe, Knierim and Frazier performed a breathtaking routine to Harry Styles' “Sign of the Times" for a 146.01 to win by more than 30 points.

  • UFC free fight: Yair Rodriguez knocks out Andre Fili with insane switch kick

    Watch one of Yair Rodriguez's most brutal knocks out ahead of UFC 284.